Skip to main content
. 2010 Jan 6;12(3):265–273. doi: 10.1093/neuonc/nop028

Table 3.

SV2A immunoreactivity in glial and glioneuronal tumors

A II (n = 4) A III (n = 5) GBM (n = 30) O II (n = 4) O III (n = 8) GG (n = 6) DNT (n = 6)
Intensity score 1.5 ± 0.2 1.2 ± 0.2 1.0 ± 0.1 0.9 ± 0.3 1.2 ± 0.3 1.5 ± 0.4 1.3 ± 0.4

A II, astrocytoma WHO II; A III, astrocytoma WHO III; GBM, glioblastoma multiforme; O II, oligodendroglioma WHO II; O III, Oligodendroglioma, WHO III; GG, ganglioglioma; DNT, dysembryoplastic neuroepithelial tumor.